Humana (HUM) Net Income towards Common Stockholders (2009 - 2026)

Humana (HUM) has reported Net Income towards Common Stockholders for 18 consecutive years, with $714.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Net Income towards Common Stockholders rose 27.05% year-over-year to $714.0 million; the TTM figure through Jun 2026 stood at $1.4 billion (down 19.15% YoY), while the FY2025 annual figure was $1.3 billion, changed 0.23% from the prior year.
• Net Income towards Common Stockholders fell to $714.0 million in Q2 2026 per HUM's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $1.3 billion in Q1 2025 and bottomed at -$762.0 million in Q4 2025.
• Historically, Net Income towards Common Stockholders has averaged $548.9 million across 5 years, with a median of $704.5 million in 2022.
• Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders sank 3869.23% — and 2025, when it surged 68.41%.
• Humana's Net Income towards Common Stockholders stood at -$13.0 million in 2022, then tumbled by 3869.23% to -$516.0 million in 2023, then decreased by 25.19% to -$646.0 million in 2024, then declined by 17.96% to -$762.0 million in 2025, then surged by 193.7% to $714.0 million in 2026.
• Business Quant data shows HUM's Net Income towards Common Stockholders at $714.0 million in Q2 2026, $1.2 billion in Q1 2026, and -$762.0 million in Q4 2025.